| P2093 | author name string | W Priebe | |
| | Y Zou | |
| | Y H Ling | |
| | R Perez-Soler | |
| P2860 | cites work | Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors | Q33649082 |
| | Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites | Q33832954 |
| | Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity | Q35334208 |
| | Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model | Q35992199 |
| | Increased accumulation of drugs in multidrug-resistant cells induced by liposomes | Q41621054 |
| | Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes | Q41707670 |
| | 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks. | Q41726889 |
| | Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes | Q43973334 |
| | Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine | Q44041827 |
| | Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors | Q45933926 |
| | Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies | Q46008577 |
| | Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery | Q48126354 |
| | Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A. | Q50892060 |
| | In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes. | Q54243874 |
| | Resistance to N-benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reduced N-benzyladriamycin-14-valerate accumulation | Q54268205 |
| | Anthracycline antibiotics with high liposome entrapment: structural features and biological activity. | Q54319513 |
| | Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. | Q54321703 |
| | Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin | Q69173245 |
| | Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes | Q69485193 |
| | Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II) | Q69688098 |
| | Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice | Q69746848 |
| | Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes | Q70048929 |
| | Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice | Q70474850 |
| | Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin | Q70804646 |
| | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation | Q71030236 |
| | Intensely potent morpholinyl anthracyclines | Q71330071 |
| P433 | issue | 3 | |
| P304 | page(s) | 190-196 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles | |
| P478 | volume | 32 | |